This section is not available in the published analysis.
LEXEO Therapeutics: Business overview
LEXEO Therapeutics specializes in gene therapy aimed at treating genetically defined cardiovascular diseases and central nervous system disorders, particularly focusing on conditions like Friedreich's Ataxia and Alzheimer's disease. The company is committed to advancing science with curative potential through strategic partnerships and innovative research.